Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biochimica et Biophysica Acta - Reviews on Cancer is Scopus-indexed (Q1, CiteScore 14.1), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 0304-419XVerify ISSN ↗1879-2561Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$5,070 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 16 / 357 | 95th | Q1 |
| Oncology | 33 / 428 | 92nd | Q1 |
| Cancer Research | 25 / 233 | 89th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1974–present, best quartile Q1, CiteScore 14.1.
Biochimica et Biophysica Acta - Reviews on Cancer is Q1 in Genetics (rank 16 of 357), Q1 in Oncology (rank 33 of 428) and Q1 in Cancer Research (rank 25 of 233), by CiteScore 2025.
Biochimica et Biophysica Acta - Reviews on Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 14.1, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.882, quartile Q1, with an H-index of 174.
The publisher lists an article processing charge of about US$5,070 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biochimica et Biophysica Acta - Reviews on Cancer is published by Elsevier B.V. Its print ISSN is 0304-419X and its online ISSN is 1879-2561.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biochimica et Biophysica Acta - Reviews on Cancer has an h-index of 209 and a 2-year mean of 7.47 citations per paper (OpenAlex). Its Scopus CiteScore is 14.1, quartile Q1. On 2-year citations it ranks #20 of 353 Scopus journals in Genetics.
Biochimica et Biophysica Acta - Reviews on Cancer published 266 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from China (55.2%), United States (8.1%) and India (7.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.